Minerva Surgical Investor Relations Material
Latest events
Q2 2023
Minerva Surgical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Minerva Surgical Inc
Access all reports
Minerva Surgical Inc. is a medical device company focused on developing minimally invasive solutions for the treatment of abnormal uterine bleeding (AUB). The company's flagship product, the Minerva Endometrial Ablation System, is designed to treat AUB by removing the endometrial lining of the uterus. Minerva’s products aim to provide effective, less invasive alternatives to hysterectomy, improving outcomes for women suffering from AUB. The company is headquartered in Santa Clara, California, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
UTRS
Country
🇺🇸 United States